Home/Filings/4/0000899243-21-012547
4//SEC Filing

Pare Anthony 4

Accession 0000899243-21-012547

CIK 0001492674other

Filed

Mar 17, 8:00 PM ET

Accepted

Mar 18, 4:34 PM ET

Size

5.1 KB

Accession

0000899243-21-012547

Insider Transaction Report

Form 4
Period: 2021-03-17
Pare Anthony
Chief Commercial Officer
Transactions
  • Sale

    Common Stock

    2021-03-17$1.84/sh9,620$17,70131,612 total
Footnotes (2)
  • [F1]The transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
  • [F2]The price reported is a weighted average price. These shares were sold in multiple transactions at per share prices ranging from $1.80 to $1.89. The reporting person undertakes to provide upon request to the SEC staff, the Issuer, or any stockholder of the Issuer, full information regarding the number of shares sold at each separate price within the range set forth in this footnote

Issuer

T2 Biosystems, Inc.

CIK 0001492674

Entity typeother

Related Parties

1
  • filerCIK 0001418863

Filing Metadata

Form type
4
Filed
Mar 17, 8:00 PM ET
Accepted
Mar 18, 4:34 PM ET
Size
5.1 KB